麻豆女优

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 麻豆女优 Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Requirements
  • ‘Skinny Labeling’
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

TRENDING TOPICS:

  • Medicaid Work Requirements
  • 'Skinny Labeling'
  • Gun Control
  • Suicide Prevention
  • Rural Health Payout

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 1 2016

Full Issue

Embattled Zenefits Cuts Deals With Investors In Effort To Reset Reputation

The move cuts the once-celebrated company's valuation to about $2 billion.

Zenefits investors are getting a larger piece of the troubled human resources start-up because they overpaid for their stakes, unaware that the company鈥檚 sales teams flouted regulations to enhance growth, Zenefits announced on Thursday. The move will cut the company鈥檚 valuation in half, to about $2 billion. The unusual agreement comes after months of turmoil at Zenefits, once a high-flying company that helps small businesses buy insurance. (Benner and Isaac, 6/30)

Embattled health-benefits broker Zenefits on Thursday said it struck a deal with some investors to cut its valuation by more than half to $2 billion, giving them additional shares in exchange for releasing the company of potential legal claims. Zenefits, a once highflying startup that in just two years after its founding was valued at $4.5 billion, has been reeling from regulatory investigations, stalled sales, layoffs and management missteps. On Thursday, Zenefits鈥檚 recently installed chief executive, David Sacks, said the company has been trying to work out a deal with investors to move past the problems. (Winkler, 6/30)

Software startup Zenefits has cut a highly unusual deal with investors to increase their ownership while slashing the once-hot firm's valuation as it seeks to avoid litigation and mend damage in the wake of revelations of cheating. The deal, a concession to investors in the firm's latest funding round, will boost the investors' combined stake to about 25 percent from about 11 percent but cuts the Zenefits' valuation by more than half to $2 billion from $4.5 billion. (Somerville and Todd, 7/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, April 30
  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 麻豆女优